Matches in SemOpenAlex for { <https://semopenalex.org/work/W3124282273> ?p ?o ?g. }
- W3124282273 endingPage "138" @default.
- W3124282273 startingPage "138" @default.
- W3124282273 abstract "Simvastatin (SIM) is a HMG-CoA reductase inhibitor employed in the management of hyperlipidemia. However, its low bioavailability limits its clinical efficacy. The objective of this study was to overcome the poor bioavailability of SIM via the transdermal application of a SIM-loaded niosomal gel. Niosomes loaded with SIM were fabricated by means of the thin-film hydration method and optimized through a 33-factorial design utilizing Design Expert® software. The prepared niosomes were evaluated for entrapment efficiency (EE%), zeta potential, vesicle size, and cumulative percentage of drug release. The optimum niosomal formulation was loaded on the gel and evaluated for physical properties such as color, clarity, and homogeneity. It was also evaluated for spreadability, and the cumulative % drug release. The best niosomal gel formula was appraised for ex vivo permeation as well as pharmacokinetic study. The SIM-loaded niosomes showed EE% between 66.7–91.4%, vesicle size between 191.1–521.6 nm, and zeta potential ranged between −0.81–+35.6 mv. The cumulative percentage of drug released was ranged from 55% to 94% over 12 h. SIM-loaded niosomal gels were clear, homogenous, spreadable, and the pH values were within the range of physiological skin pH. Furthermore, about 73.5% of SIM was released within 24 h, whereas 409.5 µg/cm2 of SIM passed through the skin over 24 h in the ex vivo permeation study. The pharmacokinetic study revealed higher AUC0–∞ and Cmax with topical application of SIM-loaded niosomal gel compared to topical SIM gel or oral SIM suspension. The topical application of SIM-loaded niosomal gel ascertained the potential percutaneous delivery of SIM." @default.
- W3124282273 created "2021-02-01" @default.
- W3124282273 creator A5028331711 @default.
- W3124282273 creator A5040459893 @default.
- W3124282273 creator A5049521775 @default.
- W3124282273 creator A5069821684 @default.
- W3124282273 creator A5087947799 @default.
- W3124282273 date "2021-01-21" @default.
- W3124282273 modified "2023-10-16" @default.
- W3124282273 title "Fabrication and Appraisal of Simvastatin via Tailored Niosomal Nanovesicles for Transdermal Delivery Enhancement: In Vitro and In Vivo Assessment" @default.
- W3124282273 cites W1901552567 @default.
- W3124282273 cites W1964826558 @default.
- W3124282273 cites W1970416499 @default.
- W3124282273 cites W1973231585 @default.
- W3124282273 cites W1974120683 @default.
- W3124282273 cites W1975692184 @default.
- W3124282273 cites W1976821125 @default.
- W3124282273 cites W1981433605 @default.
- W3124282273 cites W1986127750 @default.
- W3124282273 cites W1986180844 @default.
- W3124282273 cites W1988400258 @default.
- W3124282273 cites W1998022180 @default.
- W3124282273 cites W2001630938 @default.
- W3124282273 cites W2010311410 @default.
- W3124282273 cites W2024363028 @default.
- W3124282273 cites W2038451015 @default.
- W3124282273 cites W2045316892 @default.
- W3124282273 cites W2058009653 @default.
- W3124282273 cites W2060287557 @default.
- W3124282273 cites W2066432116 @default.
- W3124282273 cites W2078900401 @default.
- W3124282273 cites W2086130473 @default.
- W3124282273 cites W2095875226 @default.
- W3124282273 cites W2096240924 @default.
- W3124282273 cites W2097675279 @default.
- W3124282273 cites W2109709772 @default.
- W3124282273 cites W2160760798 @default.
- W3124282273 cites W2166458266 @default.
- W3124282273 cites W2169313892 @default.
- W3124282273 cites W2175851332 @default.
- W3124282273 cites W2327028063 @default.
- W3124282273 cites W2372848131 @default.
- W3124282273 cites W2484367007 @default.
- W3124282273 cites W2495709913 @default.
- W3124282273 cites W2501605053 @default.
- W3124282273 cites W2518933690 @default.
- W3124282273 cites W2766720408 @default.
- W3124282273 cites W2791283433 @default.
- W3124282273 cites W2795797914 @default.
- W3124282273 cites W2805779846 @default.
- W3124282273 cites W2888522877 @default.
- W3124282273 cites W2896032560 @default.
- W3124282273 cites W2903762433 @default.
- W3124282273 cites W2904990515 @default.
- W3124282273 cites W2912500870 @default.
- W3124282273 cites W2913725137 @default.
- W3124282273 cites W2914096421 @default.
- W3124282273 cites W2921550223 @default.
- W3124282273 cites W2944449629 @default.
- W3124282273 cites W2944551644 @default.
- W3124282273 cites W2952833789 @default.
- W3124282273 cites W3009481919 @default.
- W3124282273 cites W3015583380 @default.
- W3124282273 cites W3027413586 @default.
- W3124282273 cites W3097756132 @default.
- W3124282273 cites W4235358290 @default.
- W3124282273 doi "https://doi.org/10.3390/pharmaceutics13020138" @default.
- W3124282273 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7910921" @default.
- W3124282273 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33494472" @default.
- W3124282273 hasPublicationYear "2021" @default.
- W3124282273 type Work @default.
- W3124282273 sameAs 3124282273 @default.
- W3124282273 citedByCount "24" @default.
- W3124282273 countsByYear W31242822732021 @default.
- W3124282273 countsByYear W31242822732022 @default.
- W3124282273 countsByYear W31242822732023 @default.
- W3124282273 crossrefType "journal-article" @default.
- W3124282273 hasAuthorship W3124282273A5028331711 @default.
- W3124282273 hasAuthorship W3124282273A5040459893 @default.
- W3124282273 hasAuthorship W3124282273A5049521775 @default.
- W3124282273 hasAuthorship W3124282273A5069821684 @default.
- W3124282273 hasAuthorship W3124282273A5087947799 @default.
- W3124282273 hasBestOaLocation W31242822731 @default.
- W3124282273 hasConcept C105795698 @default.
- W3124282273 hasConcept C112705442 @default.
- W3124282273 hasConcept C130316041 @default.
- W3124282273 hasConcept C150903083 @default.
- W3124282273 hasConcept C155672457 @default.
- W3124282273 hasConcept C169222746 @default.
- W3124282273 hasConcept C171250308 @default.
- W3124282273 hasConcept C181389837 @default.
- W3124282273 hasConcept C185592680 @default.
- W3124282273 hasConcept C192562407 @default.
- W3124282273 hasConcept C202751555 @default.
- W3124282273 hasConcept C205679159 @default.
- W3124282273 hasConcept C207001950 @default.
- W3124282273 hasConcept C22979827 @default.
- W3124282273 hasConcept C26291073 @default.